Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Giant serous papillary cystadenoma.

Literature DB >> 27365823

Giant serous papillary cystadenoma.

Madhusudan Dey¹, Niloy Pathak².

Abstract

Entities: Disease

Year: 2011 PMID： 27365823 PMCID： PMC4920867 DOI： 10.1016/S0377-1237(11)60059-2

Source DB: PubMed Journal: Med J Armed Forces India ISSN： 0377-1237

× No keyword cloud information.

5 in total

1. Prevalence screening for ovarian cancer in postmenopausal women by CA 125 measurement and ultrasonography.

Authors: I Jacobs; A P Davies; J Bridges; I Stabile; T Fay; A Lower; J G Grudzinskas; D Oram
Journal: BMJ Date: 1993-04-17

2. The characterization of common ovarian cysts in premenopausal women.

Authors: K Jermy; C Luise; T Bourne
Journal: Ultrasound Obstet Gynecol Date: 2001-02 Impact factor: 7.299

3. Soluble epidermal growth factor receptor (sEGFR) [corrected] and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancer.

Authors: Andre T Baron; Cecelia H Boardman; Jacqueline M Lafky; Alfred Rademaker; Dachao Liu; David A Fishman; Karl C Podratz; Nita J Maihle
Journal: Cancer Epidemiol Biomarkers Prev Date: 2005-02 Impact factor: 4.254

4. The risk-of-malignancy index to evaluate potential ovarian cancers in local hospitals.

Authors: S Tingulstad; B Hagen; F E Skjeldestad; T Halvorsen; K Nustad; M Onsrud
Journal: Obstet Gynecol Date: 1999-03 Impact factor: 7.661

5. Peritoneal epithelial lesions associated with proliferative serous tumours of ovary.

Authors: W T McCaughey; M E Kirk; W Lester; I Dardick
Journal: Histopathology Date: 1984-03 Impact factor: 5.087

5 in total

3 in total

Giant serous papillary cystadenoma.

1. Prevalence screening for ovarian cancer in postmenopausal women by CA 125 measurement and ultrasonography.

2. The characterization of common ovarian cysts in premenopausal women.

3. Soluble epidermal growth factor receptor (sEGFR) [corrected] and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancer.

4. The risk-of-malignancy index to evaluate potential ovarian cancers in local hospitals.

5. Peritoneal epithelial lesions associated with proliferative serous tumours of ovary.

1. A Postmenopausal Woman with Giant Ovarian Serous Cyst Adenoma: A Case Report with Brief Literature Review.

2. Role of Neoadjuvant Chemotherapy in Ovarian Serous Cancer Followed by Debulking.

3. [Huge ovarian tumor in a perimenopausal woman: a case report].